There Is A Quest For Clarity Surrounding Dynavax Technologies Corp. (NASDAQ: DVAX) Volatility

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $12.06 and fluctuated between $12.29 as its day high and $12.06 as its day low. The current market capitalization of Dynavax Technologies Corp. is $1.58B. A total of 1.05 million shares were traded on the day, compared to an average of 2.11M shares.

In the most recent transaction, CANO FRANCIS sold 3,615 shares of DVAX for 11.93 per share on May 31 ’24. After the transaction, the Director now owns 36,905 company shares. In a previous transaction on Mar 01 ’24, Burgess Justin sold 20,526 shares at 12.78 per share. DVAX shares that Chief Accounting Officer owns now total 0.

Among the insiders who sold shares, Janssen Robert disposed of 1,500 shares on Jan 04 ’24 at a per-share price of $15.00. This resulted in the SVP and CMO holding 49,925 shares of DVAX after the transaction. In another insider transaction, Novack David F sold 9,000 shares at $14.45 per share on Jan 02 ’24. Company shares held by the President & COO now total 3,187.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, DVAX has a high of $15.15 and a low of $10.48.

As of this writing, DVAX has an earnings estimate of $0.07 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.1 per share and a lower estimate of $0.03. The company reported an EPS of $0.03 in the last quarter

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DVAX’s latest balance sheet shows that the firm has $545.95M in Cash & Short Term Investments as of fiscal 2021. There were $257.38M in debt and $556.40M in liabilities at the time. Its Book Value Per Share was $4.73, while its Total Shareholder’s Equity was $222.37M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Buy with a score of 4.60.

Most Popular

Related Posts